|
Real-time Estimate
Cboe BZX
07:49:39 13/03/2026 pm IST
|
5-day change
|
1st Jan Change
|
|
50.96 USD
|
+2.89%
|
 |
-2.93%
|
-14.09%
|
|
11/03 |
Tempus Ai, Inc. Announces the Publication of A New Study in Jco Precision Oncology
|
CI
| |
11/03 |
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
|
BU
| |
05/03 |
Tempus AI Insider Sold Shares Worth $578,576, According to a Recent SEC Filing
|
MT
| |
03/03 |
Tempus AI, Inc. Presents at Morgan Stanley Technology, Media & Telecom Conference 2026, Mar-03-2026 09:15 AM
| | |
03/03 |
Tempus AI, Inc. Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
|
CI
| |
03/03 |
Tempus announces strategic collaboration agreement with Merck to accelerate AI-driven precision medicine
|
RE
| |
03/03 |
Tempus AI, Merck Collaborate on AI-Driven Precision Medicine
|
MT
| |
03/03 |
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
|
BU
| |
26/02 |
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
|
BU
| |
25/02 |
Analyst recommendations: IBM, Axon, Caterpillar, Fair Isaac, Gilead…
|  | |
25/02 |
Tempus AI, Inc., Q4 2025 Earnings Call, Feb 24, 2026
| | |
25/02 |
Tempus AI Q4 Non-GAAP Loss Narrows, Revenue Rises; 2026 Revenue Outlook Set
|
MT
| |
25/02 |
Tempus AI : 4Q25 Corporate Deck
|
PU
| |
25/02 |
Tempus: Q4 Earnings Snapshot
|
AQ
| |
25/02 |
(TEM) Tempus AI Expects 2026 Revenue of About $1.59B, vs. FactSet Est of $1.58B
|
MT
| |
25/02 |
Tempus AI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
|
CI
| |
25/02 |
Earnings Flash (TEM) Tempus AI, Inc. Reports Q4 Revenue $367.2M, vs. FactSet Est of $362.7M
|
MT
| |
25/02 |
Earnings Flash (TEM) Tempus AI, Inc. Posts Q4 Adjusted Loss $0.04 per Share, vs. FactSet Est of $-0.04
|
MT
| |
25/02 |
Tempus Reports Fourth Quarter and Full Year 2025 Results
|
BU
| |
25/02 |
Tempus AI, Inc. Provides Earnings Guidance for the Full Year 2026
|
CI
| |
24/02 |
Tempus AI, Inc. acquired Oneome LLC.
|
CI
| |
19/02 |
Mizuho Securities Initiates Coverage on Tempus AI With Outperform Rating, $100 Price Target
|
MT
| |
18/02 |
Tempus AI, Inc. Announces Novel Pan-Cancer HRD-RNA Algorithm
|
CI
| |
18/02 |
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
|
BU
| |
17/02 |
Baird Initiates Tempus AI at Outperform With $59 Price Target
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
